In the BioHarmony Drug Report Database

"Preview" Icon

Palifermin

Kepivance (palifermin) is a protein pharmaceutical. Palifermin was first approved as Kepivance on 2004-12-15. It is used to treat mucositis in the USA. The pharmaceutical is active against fibroblast growth factor receptor 2.

 

Trade Name

 

Kepivance
 

Common Name

 

palifermin
 

ChEMBL ID

 

CHEMBL1201821
 

Indication

 

mucositis
 

Drug Class

 

Growth factors: fibroblast growth factors

Image (chem structure or protein)

Palifermin structure rendering